Simon D.

Simon D. has held significant leadership roles in various companies, including serving as Chairman and CEO of Obagi from June 2020 to July 2022, and Director at Waldencast since July 2022. Prior experience includes a Directorship at Obagi Medical from November 2017 to 2020 and Co-Chairman & CEO at Presbia, a medical device company, from December 2019 to July 2022, where focus was on developing the Presbia Flexivue Microlens™. Additionally, Simon D. is the Founder and Managing Director of Cedarwalk Capital, a position held since May 2021. Academic credentials include an MBA from UCLA Anderson School of Management, a Bachelor’s degree in Sociology from The University of Manchester, and a Master’s degree in Finance from The London School of Economics and Political Science.